Keith Stockerl-Goldstein

1.0k total citations
5 papers, 5 citations indexed

About

Keith Stockerl-Goldstein is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Keith Stockerl-Goldstein has authored 5 papers receiving a total of 5 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Public Health, Environmental and Occupational Health and 1 paper in Genetics. Recurrent topics in Keith Stockerl-Goldstein's work include Acute Lymphoblastic Leukemia research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Keith Stockerl-Goldstein is often cited by papers focused on Acute Lymphoblastic Leukemia research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Keith Stockerl-Goldstein collaborates with scholars based in United States. Keith Stockerl-Goldstein's co-authors include Amanda F. Cashen, Michael Slade, Amanda F. Cashen, Zachary Crees, John F. DiPersio, Camille N. Abboud, Matthew Christopher, Peter Westervelt, Iskra Pusic and Feng Gao and has published in prestigious journals such as Blood and Transplantation and Cellular Therapy.

In The Last Decade

Keith Stockerl-Goldstein

3 papers receiving 5 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Stockerl-Goldstein United States	2	5	4	1	1	1	5	5
Caroline Gabe Canada	2	5 1.0×	3 0.8×				3	7
Céline Comparon France	3	4 0.8×	6 1.5×		1 1.0×	1 1.0×	4	11
Madeleine Tooley United Kingdom	2	3 0.6×	3 0.8×	1 1.0×		1 1.0×	3	7
Gillian Moore United States	2	8 1.6×	8 2.0×	1 1.0×		1 1.0×	3	11
Jose Antonio Pérez de León Spain	2	3 0.6×	3 0.8×	1 1.0×			2	4
A. Kapuağası Türkiye	2	5 1.0×	3 0.8×	2 2.0×		2 2.0×	2	8
Loreto Horcada Spain	2	2 0.4×	3 0.8×				4	5
Diederik W.J. Dippel Netherlands	2	3 0.6×	2 0.5×		2 2.0×		2	6
Paola Everardo Mexico	2	2 0.4×	3 0.8×				2	5

Countries citing papers authored by Keith Stockerl-Goldstein

Since Specialization

Citations

This map shows the geographic impact of Keith Stockerl-Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Stockerl-Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Stockerl-Goldstein more than expected).

Fields of papers citing papers by Keith Stockerl-Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Stockerl-Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Stockerl-Goldstein. The network helps show where Keith Stockerl-Goldstein may publish in the future.

Co-authorship network of co-authors of Keith Stockerl-Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Stockerl-Goldstein. A scholar is included among the top collaborators of Keith Stockerl-Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Stockerl-Goldstein. Keith Stockerl-Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Crees, Zachary, Keith Stockerl-Goldstein, Feng Gao, et al.. (2025). A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate E-Selectin Inhibition with Uproleselan to Reduce Gastrointestinal Toxicity During Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Transplantation and Cellular Therapy. 32(3). 231.e1–231.e4.

2.

Stockerl-Goldstein, Keith, et al.. (2024). Real-World Experience with Elotuzumab, Pomalidomide, and Dexamethasone As Second or Third-Line Therapy in Relapsed and Refractory Multiple Myeloma. Blood. 144(Supplement 1). 6936–6936.

3.

Abboud, Ramzi, Mark A. Schroeder, Michael P. Rettig, et al.. (2024). Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation. Blood. 145(13). 1382–1394. 1 indexed citations

4.

Abboud, Ramzi, Mark A. Schroeder, Michael P. Rettig, et al.. (2023). Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome with T-Cell Replete Peripheral Blood Haploidentical Transplantation. Blood. 142(Supplement 1). 651–651. 3 indexed citations

5.

Abboud, Ramzi, Feng Gao, Michael P. Rettig, et al.. (2022). A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome in T-Cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(3). S298–S299. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact